Connect with us

News

Cracks are starting to form on fusion energy’s funding boom

info

Published

on

GettyImages 1092180978.jpg

It happens in every emerging industry: founders and investors push toward a common goal, until the money starts to roll in and that shared vision begins to diverge.

Cracks are emerging in the fusion power world, which I saw firsthand at The Economist’s Fusion Fest in London last week. It didn’t dampen the overall buoyant mood, lifted by fusion startups’ fundraising haul of $1.6 billion in the last 12 months. But people had differing opinions on two key questions: When should fusion startups go public? And are side businesses a distraction?

Going public was at the top of everyone’s minds. In the last four months, TAE Technologies and General Fusion have announced plans to merge with publicly traded companies. Both stand to receive hundreds of millions of dollars to keep their R&D efforts alive, and investors, some of whom have kept the faith for 20 years, finally see an opportunity to cash out.

Not everyone is in agreement. Most of those who I spoke to were worried these companies were going public far too early and that they hadn’t achieved key milestones that many view as vital in judging the progress of a fusion company.

First, a recap: TAE announced its merger with Trump Media & Technology Group in December. Though the deal isn’t yet completed, the fusion side of the business has already received $200 million of a potential $300 million in cash from the deal, giving it some runway to continue planning its power plant. (The remainder will reportedly land in its bank account once it files the S-4 form with the U.S. Securities and Exchange Commission.)

General Fusion said in January that it would go public via a reverse merger with a special purpose acquisition company. The deal could net the company $335 million and value the combined entity at $1 billion. 

Both companies could use the cash.

Techcrunch event

San Francisco, CA
|
October 13-15, 2026

Before the merger announcement, General Fusion was struggling to raise funds, and around this time last year it laid off 25% of its staff as CEO Greg Twinney posted a public letter pleading for investment. It received a brief reprieve in August when investors threw it a $22 million lifeline, but that sort of money doesn’t last long in the fusion world, where equipment, experiments, and employees don’t come cheap.

TAE’s position wasn’t quite as dire, but it still required some funds. Pre-merger, the company raised nearly $2 billion, which sounds like a lot, but keep in mind the company is nearly 30 years old. What’s more, its valuation pre-merger was $2 billion, according to PitchBook. Investors were breaking even at best.

Neither company has hit scientific breakeven, a key milestone that shows a reactor design has power plant potential. Many observers doubt they’ll hit that mark before other privately held startups do. One executive told me, if they were in those shoes, they’re not sure how they would fill time on quarterly earnings calls if the companies didn’t hit scientific breakeven soon.

If TAE or General Fusion doesn’t deliver results, several people feared the public markets would sour on the entire fusion industry.

Now, not all may be lost. TAE has already started marketing other products, including power electronics and radiation therapy for cancer. That could give the company some near-term revenue to placate shareholders. General Fusion, though, hasn’t revealed any such plans.

And therein lies another divide: fusion companies remain split on whether they should pursue revenue now or wait until they have a working power plant.

Some companies are embracing the opportunity to make money along the way. Not a bad strategy! Fusion is a long game, so why not improve your odds? Both Commonwealth Fusion Systems and Tokamak Energy have said they’ll be selling magnets. TAE and Shine Technologies are both in nuclear medicine.

Other startups are worried that side hustles could become a distraction. Inertia Enterprises, for example, told me that they’re laser-focused on their power plant. That jibes with what another investor told me months ago: — they were worried that fusion startups could get distracted by profitable, but tangential businesses and fall off the lead. 

There wasn’t consensus on the right time to go public either. I heard a few proposed milestones. Some believe startups should first reach that scientific breakeven milestone, in which a fusion reaction generates more energy than it needs to ignite. No startup has achieved that yet. The other possibilities are facility breakeven — when the reactor makes more energy than the entire site needs to operate — and commercial viability — when a reactor makes enough electrons to sell a meaningful amount to the grid.

We may have an answer to that question sooner than later. Commonwealth Fusion Systems expects it will hit scientific breakeven sometime next year, and some think the company might use that as an opportunity to go public.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Bukayo Saka Parries Concern Over His Injury Status, After Missing England’s 4-2 Victory Versus Croatia

info

Published

on

By

IMG 20260618 WA0004.jpg

Arsenal star, Bukayo Saka has parried worries over his injury status and insists he is ready to play for England at the ongoing FIFA World Cup, where he sat out his team’s opening match on Wednesday, Sports247 reports.

England dumped Croatia 4-2 at AT&T Stadium in Dallas, Texas in their Group L opener, but Saka was not part of The Three Lions’ squad that got deserved revenge for their loss to the same country in the Russia 2018 semi-finals.

Read Also: Arike Ogunbowale Shakes USA’s Women’s NBA With 22 Points, Five 3-pointers In Dallas Wings’ Victory

The Gunners’ winger was always a major worry ahead of Wednesday’s game, as he is still recovering from a nagging achilles injury that he picked up earlier this season with his club.

However, Saka said he is feeling better and ready to play the next game, as he is eager to defy all odds, but admitted that it all depends on The Lions’ coach, Thomas Tuchel, who decides the squad’s line-up.

“I don’t want to say anything that goes against the manager. But what I would say between Mikel (Arteta) and Arsenal, since March, they have managed me amazingly and helped me get back on the pitch.

“I am feeling better than I have felt for the last few months. I am ready to go. As players it’s the biggest gamble, especially if you’re not feeling your sharpest. You have the choice whether you don’t play or you put yourself out there knowing people are going to judge you.

“I’m happy to take the gamble. It (often pays) off, I’d say. I’m going to continue doing that. But I am feeling a lot better than I did in March and I’m ready to go,” Saka submitted philosophically.

Sports247 reports further that it’s now left to be seen if Tuchel will consider Saka fit enough to start against Ghana next week in England’s second game of the ongoing Mundial in USA, Canada and Mexico.

Continue Reading

Business

Insider Dealing: Mutual Benefits Director, Ogunbiyi Sells Shares Worth Over ₦6.3 Million

info

Published

on

By

IMG 1755.jpeg

BY NKECHI NAECHE-ESEZOBOR—Mutual Benefits Assurance Plc has disclosed an insider transaction involving one of its directors, Dr. Akinade Ogunbiyi, who sold more than 1.5 million shares in the insurance company in a deal valued at over ₦6.3 million.

The disclosure, signed by Jide Ibitayo, Company Secretary, filed with the Nigerian Exchange (NGX) and the investing public, showed that Ogunbiyi, a Non-Executive Director of the company, disposed of 1,507,309 ordinary shares of Mutual Benefits Assurance Plc between June 3 and June 9, 2026.

According to the notification, the shares were sold at prices ranging from ₦4.20 to ₦4.33 per share, placing the total value of the transaction at between ₦6.33 million and ₦6.53 million.

The transaction was reported as an initial notification of insider dealing in line with regulatory requirements that mandate directors and other insiders of listed companies to disclose transactions involving the securities of their companies.

Mutual Benefits Assurance identified the financial instrument involved in the transaction as its ordinary shares, traded on the Nigerian Exchange under the ticker symbol “MBENEFIT.”
Insider dealing notifications are a key component of market transparency and corporate governance, providing investors with information on share transactions undertaken by directors, executives, and other individuals with access to potentially price-sensitive information.

While insider transactions often attract investor attention, market analysts note that such dealings do not necessarily indicate changes in a company’s outlook, as they may be influenced by personal investment decisions, portfolio rebalancing, or other financial considerations.

The disclosed transaction took place in Lagos, Nigeria, and was executed over a seven-day period between June 3 and June 9, 2026.

Mutual Benefits Assurance Plc remains one of the companies listed on the Nigerian Exchange that regularly complies with insider dealing disclosure requirements, reinforcing transparency in the capital market.

The post Insider Dealing: Mutual Benefits Director, Ogunbiyi Sells Shares Worth Over ₦6.3 Million appeared first on Business Today NG.

Continue Reading

Trending